What's Next for Tilray Brands After Posting Record Q2 Revenues?

14.01.26 13:46 Uhr

Werte in diesem Artikel

Tilray Brands TLRY delivered net revenues of $217.5 million in the second quarter of fiscal 2026, a quarterly record driven by strong results in the company’s international operations. On a year-over-year basis, revenues were up 3%. The company’s Distribution business was the lead contributor, up 26% year over year to $85.3 million, based on the increasing focus on competitive pricing, the prioritization of high-margin SKUs and favorable foreign exchange impacts.Following the temporary effect from the timing of import and export permits in the fiscal first quarter, the international cannabis business recorded a 36% increase in the second quarter. With international cannabis growth accelerating, Tilray Brands decided to scale back shipments into the Canadian wholesale market and redeploy that supply, along with new growth into the higher-margin international cannabis markets, through the rest of fiscal 2026. Overall, management is optimistic that the Distribution business will complement and strengthen the international cannabis segment as both continue to develop parallelly.Tilray Brands’ Beverage business faced pressure from category-wide headwinds in the craft beer segment, as well as from the Project 420 portfolio optimization efforts, including SKU rationalization and margin-focused initiatives continuing to impact revenues. The company expects spring retailer product resets to help offset industry trends, improving brand visibility and aligning product mix with consumer preferences. The changes are likely to support Beverage revenues and gross margins in the fiscal fourth quarter.Wellness net revenues were flat in the second quarter, supported by value-added innovation and continued growth in Hi-Ball and the Ingredient Channel. The gains were offset by challenges in the club retail channel, which the company is addressing through targeted initiatives.TLRY’s Peer UpdatesCronos Group CRON is set to acquire all the outstanding shares of CanAdelaar B.V. — the largest cannabis company operating within the Netherlands adult-use cannabis pilot program. According to CRON, the acquisition is a financially compelling and highly strategic transaction that will establish a strategic footprint in Europe and enable the company to leverage its investments in borderless products. Cronos will acquire CanAdelaar for up-front consideration of $67.0 million, with a cash earnout of 0.5X of CanAdelaar’s normalized EBITDA in 2026 and 2027.Canopy Growth CGC has entered into a series of transactions to recapitalize its balance sheet and extend the maturity dates of all outstanding indebtedness to January 2031 at the earliest. At the conclusion of these Transactions, Canopy Growth is expected to have cash on hand of approximately C$425 million, providing additional flexibility to support its long-term priorities.The Zacks Rundown for TLRYIn the past six months, Tilray Brands shares have surged 58.4% against the industry’s 6.5% fall.Image Source: Zacks Investment ResearchIn terms of valuation, TLRY is trading at a forward 12-month Price-to-Sales (P/S) of 1.18X, higher than its median but below the 3.05X industry average.Image Source: Zacks Investment ResearchTake a look at how TLRY’s earnings estimates have been moving over the past 90 days.Image Source: Zacks Investment ResearchTLRY stock currently carries a Zacks Rank #5 (Strong Sell).  You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Just Released: Zacks Top 10 Stocks for 2026Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cronos Group Inc. (CRON): Free Stock Analysis Report Canopy Growth Corporation (CGC): Free Stock Analysis Report Tilray Brands, Inc. (TLRY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Q2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Tilray Brands (ex Aphria)

Wer­bung

Analysen zu Tilray Brands (ex Aphria)

DatumRatingAnalyst
14.08.2019Tilray BuyThe Benchmark Company
05.06.2019Tilray PerformOppenheimer & Co. Inc.
15.05.2019Tilray Market PerformBMO Capital Markets
21.02.2019Aphria BuySeaport Global Securities
21.02.2019Tilray NeutralSeaport Global Securities
DatumRatingAnalyst
14.08.2019Tilray BuyThe Benchmark Company
15.05.2019Tilray Market PerformBMO Capital Markets
21.02.2019Aphria BuySeaport Global Securities
16.10.2018Tilray BuyThe Benchmark Company
DatumRatingAnalyst
05.06.2019Tilray PerformOppenheimer & Co. Inc.
21.02.2019Tilray NeutralSeaport Global Securities
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tilray Brands (ex Aphria) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen